4-AcO-DALT

Last updated
4-AcO-DALT
4-AcO-DALT.svg
Clinical data
Other names4-Acetoxy-N,N-diallyltryptamine; Dalcetin
Routes of
administration
Oral
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • [3-[2-[bis(prop-2-enyl)amino]ethyl]-1H-indol-4-yl] acetate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C18H22N2O2
Molar mass 298.386 g·mol−1
3D model (JSmol)
  • CC(=O)Oc1cccc2c1c(c[nH]2)CCN(CC=C)CC=C
  • InChI=1S/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3
  • Key:WRHFDIBXZYYCHO-UHFFFAOYSA-N

4-AcO-DALT, also known as 4-acetoxy-N,N-diallyltryptamine or as dalcetin, is a tryptamine derivative. It has been sold as a designer drug, but little other information is available. It was first officially identified in seized drug samples in 2012. [1]

Contents

Interactions

Pharmacology

Pharmacodynamics

4-HO-DALT and 4-AcO-DALT produce the head-twitch response, a behavioral proxy of psychedelic-like effects, in rodents. [2] The receptor interactions of 4-HO-DALT and 4-AcO-DALT have been studied. [2] [3]

See also

References

  1. EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)
  2. 1 2 Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL (November 2018). "Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs". Neuropharmacology. 142: 231–239. doi:10.1016/j.neuropharm.2018.02.028. PMC   6230509 . PMID   29499272.
  3. Glatfelter GC, Naeem M, Pham DN, Golen JA, Chadeayne AR, Manke DR, Baumann MH (April 2023). "Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice". ACS Pharmacol Transl Sci. 6 (4): 567–577. doi:10.1021/acsptsci.2c00222. PMC   10111620 . PMID   37082754.